Previous 10 | Next 10 |
BEDFORD, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2021 financial results after the close of the market on Th...
BEDFORD, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice Presiden...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event. For further details see: Anika Therapeutics (ANIK) Presents At Sidoti Virtual Spring Investor Conference - Slideshow
Presentation Times and Weblinks Released for Over 125 Presenting Companies Wednesday and Thursday, March 24-25, 2021 NEW YORK, NY / ACCESSWIRE / March 23, 2021 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for its Spring 2021 Vir...
BEDFORD, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice Presiden...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Anika Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
Anika Therapeutics, Inc. (ANIK) Q4 2020 Earnings Conference Call March 4, 2021, 05:00 PM ET Company Participants Mark Namaroff - Executive Director of IR and Corporate Communications Cheryl Blanchard - President and CEO Michael Levitz - EVP, CFO and Treasurer Conference Call Participants Jim ...
Image source: The Motley Fool. Anika Therapeutics Inc (NASDAQ: ANIK) Q4 2020 Earnings Call Mar 4, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Anika Therapeutics Inc (ANIK) Q4 2020 Earnings Call Transcript
Anika Therapeutics (ANIK): Q4 Non-GAAP EPS of $0.12 beats by $0.01; GAAP EPS of -$1.10 misses by $1.09.Revenue of $32.69M (+9.8% Y/Y) misses by $0.81M.Press Release For further details see: Anika Therapeutics EPS beats by $0.01, misses on revenue
Completed Transformative Year with Q4 2020 Revenue Up 10% Year-Over-Year, Full Year 2020 Revenue up 14% Well Positioned for Growth in 2021 BEDFORD, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation comp...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...